4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-23-008937
CVP,Strategy/Corp Development sold 4,500 shares at $73.71 ($331,695)
- CVP,Strategy/Corp Development acquired 4,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BOBO DONALD E JR · CVP,Strategy/Corp Development
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-14 | Exercise or conversion : show line 1 in the form 10b5-1 | +4,500 | $36.75 | $165,375 | 44,002.69 | D |
| 2023-09-14 | Sale : show line 2 in the form 10b5-1 | −4,500 | $73.71 | $331,695 | 39,502.69 | D |
| Open-market sales · 4,500 sh · avg $73.71 · $331,695 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-09-14 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −4,500 | $36.75 | 2024-05-10 | 4,500 | 67,000 | D |
Loading xslF345X05/doc4.xml…